Palonosetron versus tropisetron with dexamethasone for prevention of postoperative nausea and vomiting in pediatric adenotonsillectomy: a single center, randomized controlled trial
BackgroundPostoperative nausea and vomiting (PONV) remain significant complications following pediatric adenotonsillectomy. Although palonosetron, a second-generation 5-HT3 receptor antagonist, has shown potential for preventing PONV, further research is needed to assess its efficacy when combined w...
Saved in:
Main Authors: | Hualin Chen, Liping Sun, Jijian Zheng, Hongbin Gu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-08-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1549619/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Netupitant/palonosetron (NEPA; Akynzeo®) combination in prevention of the nausea and vomiting in patients with breast cancer receiving anthracyclinbased chemotherapy
by: A. G. Kedrova, et al.
Published: (2023-10-01) -
Netupitant / palonosetron with dexamethasone for preventing nausea and vomiting in patients with multiple myeloma receiving high-dose melphalan for autologous hematopoietic stem cell transplantation: a single-center experience
by: N. E Mochkin, et al.
Published: (2025-03-01) -
Neuroendoscopy and Postoperative Nausea and Vomiting: Pathophysiology, Incidence and Management Strategies
by: Vincenzo Pota, et al.
Published: (2025-05-01) -
Postoperative Nausea and Vomiting in Cancer Surgery: Present Views on the Solution of the Old Problem
by: D. S. Baskakov, et al.
Published: (2013-04-01) -
Ginger as a non-pharmacological prevention of postoperative nausea and vomiting (PONV): a review
by: Weronika Gniado, et al.
Published: (2024-12-01)